GO
Loading...

It's Time for the Lightning Round!

Monster : Don’t give up hope, Cramer said. Monster is “one of the few great online propoerties that can still reinvent an offline business,” and he still thinks it will get sold.

Tween Brands : “This is one of the best stories around in retail,” Cramer said. Most of retail isn’t working, but TWB has great growth. “Stay in it.”

Merck : Cramer won’t go there. Merck doesn’t have the kind of growth he’s looking for.

Alcoa : Stick with Alcoa, Cramer said. He expects a good quarter when it reports Monday – and he thinks it will not be public eventually.

Fuel-Tech : Cramer said he will revisit FTEK on a pullback, but right now the whole group is too hot.

Savient Pharmaceuticals : It’s a speculative name, and Cramer likes it here on a pullback.

Comcast : “I like Comcast here.”

Sun Microsystems : Sun can go from $5.30 to $6 very quietly, Cramer said. You can make a little money there and then sell.

Smith & Wesson : Cramer thinks Smith & Wesson goes to $20.

Mylan Labs : The only pharma company Cramer is willing to back is Celgene . The rest of the group is just no good, he said.

Questions for Cramer? madmoney@cnbc.com

Questions, comments, suggestions for the Mad Money website? madcap@cnbc.com

Symbol
Price
 
Change
%Change
AA
---
CELG
---
CMCSA
---
FTEK
---
MRK
---
MYL
---
SVNTQ
---
SWHC
---

Featured

Contact Mad Money

  • Showtimes

    U.S.
    Monday - Friday 6p ET
    Australia
    Saturday 8a, 1p, 7p SYD
    Sunday 12a, 1a, 8a, 7p SYD
    New Zealand
    Saturday 10a, 3p, 9p NZ
    Sunday 2a, 3a, 10a, 9p NZ
  • Jim Cramer is host of CNBC's "Mad Money" and co-anchor of the 9 a.m. ET hour of CNBC's "Squawk on the Street."

Mad Money Features

  • Grab the latest CNBC gear from the NBCUniversal Store!

  • Get a behind-the-scenes look at how Cramer formulates his investment advice. "Inside the Madness" is a column, which features e-mails and more with Cramer and his researcher Nicole Urken.

  • You’ve always wanted to hit the “Hallelujah!” button. Here’s your chance.

Cramer's New Book